Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR, NMPA) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

Eye-tracking Investigation of Clinical Measures in Multiple Sclerosis

NCT: NCT06283524 · COMPLETED

NCT IDNCT06283524
StatusCOMPLETED
Start Date2024-03-18
Completion2026-03-18

Brief Summary

The overarching goal of this research protocol is to acquire eye-tracking, cognitive, and disease-severity metrics in MS patients to train machine learning algorithms that will support the development and performance assessment of a sensitive and non-invasive eye-tracking software application. The training of our machine learning classifying algorithms to identify which eye-tracking metrics-or combination thereof-can serve as reliable markers of MS disease severity and cognitive status.

Frequently Asked Questions

What is Eye-tracking Investigation of Clinical Measures in Multiple Sclerosis?

Eye-tracking Investigation of Clinical Measures in Multiple Sclerosis is a clinical trial registered under NCT06283524. Current status: COMPLETED.

What is the status of NCT06283524?

The current status of NCT06283524 (Eye-tracking Investigation of Clinical Measures in Multiple Sclerosis) is: COMPLETED.

When did Eye-tracking Investigation of Clinical Measures in Multiple Sclerosis start?

Eye-tracking Investigation of Clinical Measures in Multiple Sclerosis started on 2024-03-18.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.